Posted on

Drug Combination Shows Promise In Advanced Prostrate Cancer.

Posted on

Adding the poly ADP ribose polymerase (PARP) inhibitor olaparib (Lynparza, AstraZeneca) to the androgen synthesis inhibitor abiraterone acetate (Zytiga, Janssen) significantly improves progression-free survival (PFS) in men with advanced prostate cancer over abiraterone alone, UK researchers have discovered. Studying 142 patients with metastatic castration-resistant prostate cancer (mCRPC), Dr Noel Clarke, The Christie and Salford Royal…

Read more

Posted on Leave a comment

You are invited to the 4th anniversary of GDMeds

Posted on Leave a comment

4 years ago, Dr. Liya started her business aim to help her clients, and try her best to make it reliable and affordable. Up to date, she still sticks to this mission and never changes. Furthermore, to serve our clients better, this year, Apr 2018, we move to the new e-platform (GDMeds.com). We hope all…

Read more

Posted on Leave a comment

Next-Gen Sequencing for Lung Cancer: Do It Early, for All of Your Patients

Posted on Leave a comment

Next-Gen Sequencing for Lung Cancer: Do It Early, for All of Your Patients   Author: Mark G. Kris, MD Mark Kris from Memorial Sloan Kettering in New York City, talking, once again, about the benefits of doing next-generation sequencing (NGS) at diagnosis on persons with lung cancer. We’ve talked before about the need to get this…

Read more

Posted on Leave a comment

Uveal Melanoma: Better Survival With Liver Directed Therapy.

Posted on Leave a comment

  For patients with uveal melanoma, the most common eye cancer in adults, survival outcomes have improved in recent years, after treatment modalities shifted from systemic to liver-directed therapies. The finding comes from researchers at the Thomas Jefferson University in Philadelphia, Pennsylvania, and was presented at the recent American Society of Clinical Oncology (ASCO) 2018…

Read more

Posted on Leave a comment

FDA Approves Pegfilgrastim Biosimilar for Cancer Infection Risk

Posted on Leave a comment

Author: Nick Mulcahy The U.S. Food and Drug Administration has approved the first biosimilar to pegfilgrastim (Neulasta, Amgen), a granulocyte colony-stimulating factor used to reduce infection risk in patients with cancer. The new product is pegfilgrastim-jmdb ( Fulphila , Mylan GmbH), approved for use to decrease the risk for infection in patients with nonmyeloid cancer who are receiving…

Read more

Posted on Leave a comment

GDMeds.com explore a new way to serve the people

Posted on Leave a comment

India’s Trusted Pharmacy: Purchase Cancer Drugs Online in India No more running from one chemist store to another when in need of medicines! GDMeds.com brings to you an online medicine store, which can be accessed for all health needs. We are focused towards making healthcare accessible and affordable, especially for cancer drugs, such as chemotherapy,…

Read more

Posted on Leave a comment

New Research: An Egg A Day Keep Heart Attack Away

Posted on Leave a comment

Is eating eggs bad for your heart due to their high cholesterol content? You may make mistake, please think again. A large research has now shown that people who eat an egg every day could significantly reduce their risk of cardiovascular diseases. What an interesting thing. “The present study finds that there is an association between…

Read more

Posted on Leave a comment

‘Oncology Done Right Is About Balance’: Weighing Immunotherapy Side Effects

Posted on Leave a comment

Author: Mark G. Kris, MD Hello. This is Mark Kris from Memorial Sloan Kettering. I am speaking to you today about three papers that appeared in JAMA Oncology on January 11, 2018, dealing with the adverse effects of immune checkpoint inhibitors. There was a commentary and two papers. My issue with these presentations is the lack of discussion of benefits…

Read more

Posted on Leave a comment

Risk of Methotrexate Dosing Errors Prompts EMA Review

Posted on Leave a comment

Reporter: Megan Brook The European Medicines Agency (EMA) is reviewing the risk of dosing errors with medicines containing methotrexate. The review is based on “continued reports of overdose,” the agency announced today. Methotrexate is used to treat various inflammatory conditions, such as arthritis, psoriasis, and some cancers, such as acute lymphoblastic leukemia. Methotrexate can be taken…

Read more